Episode
Rob Freishtat- Revolutionizing Clinical Trials in Rare Disease: Efficiency and Patient-Centric Solutions
- Podcast
- Clinical Research Coach
- Published
- Jan 21, 2025
- Duration seconds
- 3160
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/clinical-research-coach-5690243/episodes/rob-freishtat-revolutionizing-clinical-trials-in-rare-disease-efficiency-and-patient-centric-solutions/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/clinical-research-coach-5690243/rob-freishtat-revolutionizing-clinical-trials-in-rare-disease-efficiency-and-patient-centric-solutions.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, I chat with Rob Freishtat, Co-Founder and President of Uncommon Cures and former emergency physician. Rob shares his journey into the world of rare disease clinical research and his mission to transform the clinical trial landscape. We discuss the unique challenges of diagnosing and treating rare diseases and the critical role of clinical trials in advancing treatments. Rob shares how Uncommon Cures , works to remove the unnecessary "barnacles" that have accumulated over decades to reduce delays and inefficiencies. With home-based visits, after hours appointments and family involvement, Rob outlines his approaches to reduce friction and improve the patient experience make clinical trials more accessible. We also explore the impact of AI in rare disease, strategies to enhance patient recruitment, and the importance of advocating for better regulatory pathways. Whether you're a patient, a healthcare professional, or simply curious about rare disease advancements, this episode offers valuable insights into the future of clinical research. Dr. Robert J. Freishtat is a highly regarded physician-executive renowned for his transformative impact on biotechnology ventures, clinical medicine, and international healthcare initiatives. With a storied professional history spanning over two decades, Dr. Freishtat has consistently demonstrated his ability to lead high-stakes organizational transformations, drive clinical solutions to the marketplace, and forge strategic global partnerships. As the President and Co-Founder of Uncommon Cures, Dr. Freishtat has transformed clinical trials for rare diseases by implementing a unique trial model that eliminated inefficiencies and accelerated drug approval processes. Under his leadership, the company has expanded…